Healthcare provider profile · identity verified

Jorge Sedas, MD

Internal Medicine · ALBUQUERQUE, NM · NPI 1710910203

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	399	105
Levothyroxine Sodium	Levothyroxine Sodium	395	107
Atorvastatin Calcium	Atorvastatin Calcium	387	107
Rosuvastatin Calcium	Rosuvastatin Calcium	336	93
Lisinopril	Lisinopril	313	91
Gabapentin	Gabapentin	266	74
Omeprazole	Omeprazole	252	80
Losartan Potassium	Losartan Potassium	237	65
Zolpidem Tartrate	Zolpidem Tartrate	227	32
Metformin Hcl	Metformin Hcl	222	69
Tamsulosin Hcl	Tamsulosin Hcl	219	63
Pregabalin	Pregabalin	213	64
Metoprolol Succinate	Metoprolol Succinate	210	59
Oxycodone Hcl	Oxycodone Hcl	208	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	191	35
Simvastatin	Simvastatin	165	46
Celecoxib	Celecoxib	154	37
Montelukast Sodium	Montelukast Sodium	150	48
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	149	19
Finasteride	Finasteride	134	43
Alendronate Sodium	Alendronate Sodium	127	40
Allopurinol	Allopurinol	122	26
Trazodone Hcl	Trazodone Hcl	116	29
Glipizide Er	Glipizide	114	32
Albuterol Sulfate Hfa	Albuterol Sulfate	107	32
Escitalopram Oxalate	Escitalopram Oxalate	105	29
Hydrochlorothiazide	Hydrochlorothiazide	101	28
Duloxetine Hcl	Duloxetine Hcl	98	31
Furosemide	Furosemide	95	26
Pantoprazole Sodium	Pantoprazole Sodium	92	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	21
Hydroxyzine Hcl	Hydroxyzine Hcl	89	29
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	88	33
Lovastatin	Lovastatin	87	22
Fluticasone Propionate	Fluticasone Propionate	84	29
Ozempic	Semaglutide	83	15
Trulicity	Dulaglutide	76	17
Carvedilol	Carvedilol	74	22
Eliquis	Apixaban	73	18
Famotidine	Famotidine	72	19
Metoprolol Tartrate	Metoprolol Tartrate	72	18
Citalopram Hbr	Citalopram Hydrobromide	69	13
Diclofenac Sodium	Diclofenac Sodium	69	21
Triamcinolone Acetonide	Triamcinolone Acetonide	64	29
Metformin Hcl Er	Metformin Hcl	62	22
Potassium Chloride	Potassium Chloride	61	19
Hydralazine Hcl	Hydralazine Hcl	59	21
Donepezil Hcl	Donepezil Hcl	58	22
Myrbetriq	Mirabegron	58	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	20
Buspirone Hcl	Buspirone Hcl	55	suppressed
Clopidogrel	Clopidogrel Bisulfate	54	15
Paroxetine Hcl	Paroxetine Hcl	54	16
Memantine Hcl	Memantine Hcl	53	13
Tizanidine Hcl	Tizanidine Hcl	53	19
Tramadol Hcl	Tramadol Hcl	53	16
Mirtazapine	Mirtazapine	52	18
Pravastatin Sodium	Pravastatin Sodium	52	14
Raloxifene Hcl	Raloxifene Hcl	51	18
Venlafaxine Hcl Er	Venlafaxine Hcl	51	14
Clonazepam	Clonazepam	50	suppressed
Jardiance	Empagliflozin	49	13
Sumatriptan Succinate	Sumatriptan Succinate	46	11
Baclofen	Baclofen	45	13
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Ibuprofen	Ibuprofen	44	21
Xarelto	Rivaroxaban	41	11
Propranolol Hcl Er	Propranolol Hcl	39	suppressed
Spironolactone	Spironolactone	39	13
Doxycycline Hyclate	Doxycycline Hyclate	38	30
Lorazepam	Lorazepam	38	suppressed
Meclizine Hcl	Meclizine Hcl	37	14
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Alprazolam	Alprazolam	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	17
Sertraline Hcl	Sertraline Hcl	35	12
Testosterone	Testosterone	34	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Azithromycin	Azithromycin	29	13
Doxepin Hcl	Doxepin Hcl	29	suppressed
Dutasteride	Dutasteride	29	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	25
Prednisone	Prednisone	28	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	17
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Glipizide	Glipizide	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	14
Ciclopirox	Ciclopirox	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	20	suppressed
Acyclovir	Acyclovir	19	11
Glyburide	Glyburide	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	12
Estradiol	Estradiol	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Linzess	Linaclotide	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Lactulose	Lactulose	17	suppressed
Nystatin	Nystatin	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Fluconazole	Fluconazole	13	12
Nifedipine Er	Nifedipine	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	12	suppressed
Glimepiride	Glimepiride	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error